SCIMEDX PHASE II GBM IGG ANTIBODY EIA TEST (1490)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II GBM IGG ANTIBODY EIA TEST medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Anti-glomerular basement membrane (GBM) antibodies (K011348 | K011348) HIGH
Effective Date: 2001-06-22

Other General Immunology Devices:

Medical DeviceComplexity
Phadia 100View Complexity
Ciba Corning Magic LiteView Complexity
Abbott Toxo-M EIA KitView Complexity
Beckman Coulter AU2700 Chemistry analyzerView Complexity
Sorin Biomedica EBK RIAView Complexity
GenBio ImmunoDOT Infectious Mono Syndrome PanelView Complexity
Siemens Dimension RxL MaxView Complexity
BRAHMS Diagnostica DYNOtest Anti-TPOView Complexity
Polymedco Polystat MonoView Complexity
EUROIMMUN Anti-HSV-1 ELISA (IgG)View Complexity